| 1/3 | Câncer Pellizzon ACA, Salvajoli JV, Fogaroli RC, Novaes PERS, Maia MAC, Ferrigno R, Nadalin W. Conventional external bean radiation therapy and high dose rate afterloading brachytherapy as a boost for patients older than 70 years. Applied Cancer Research, São Paulo: Tecmedd, v.25, n.3, p. 130-136, 2005. ISSN 1808-5512. Disponível em: http://accamargo.phlnet.com.br/applied/ACR200525p.130-136.pdf PROSTATIC NEOPLASMS; BRACHTHERAPY; MORBIDITY; TREATMENT OUTCOME |
| 2/3 | Câncer Fogelman DR, Overman MJ, Varadhachary GR, Fortuno ME. Neoadjuvant Chemoradiation for Resectable and Borderline Pancreatic Cancer: A Review. Applied Cancer Research, São Paulo: Tecmedd, v.28, n.4, p. 127-33, 2008. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR200828p.127-33.pdf PANCREATIC NEOPLASMS; MULTIMODAL TREATMENT; TREATMENT OUTCOME |
| 3/3 | Câncer Queiroz GS, Santos AFR, Pereira RJ, Pereira GLH,Freitas-Junior R. Prevalence of paresthesia, fatigue, edema and pain after treatment for breast cancer. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.4, p. 173-8, 2009. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009294p.173-8.pdf |